Functional ingredient manufacturers
Helping ingredient suppliers build the clinical evidence and claims that earn premium positioning with brand partners.
ScienceStrategyCommercialization
Scientific depth. Commercial sophistication. In equal measure.
The decisions that determine whether a science-driven company reaches its market, earns its claims, attracts capital and builds durable advantage require both. Most advisors bring one. The Seder Group was built for that intersection.
Senior advisoryExperienced counsel on the decisions that set a company's scientific and commercial course.
Embedded leadershipStrategic leadership inside your team, carrying the work from plan to market.
Experience from
- Merck & Co.
- The Wonderful Company
- PLUS Products
- Seder Portfolio Companies
25yrsBuilding a network across pharma, nutrition and consumer health
6Core disciplines, from portfolio strategy to M&A diligence
5Expert networks activated on every engagement
1Senior lead who scopes the work and does the work
How we look at an opportunity
Chemistry, health benefit, product and business, in one view.
Every engagement weighs the science and the market together, from the molecule to the shelf.
Chemistry
What the compound is, and whether it is stable, bioavailable and consistent.
Health benefit
What benefit it delivers, and what the evidence can support.
Product
How it becomes something people will use, from format and dose to taste and stability.
Business
Whether it can win, through positioning, claims, channels and margin.
The full range
Compounds, Ingredients, and Formats
Ingredient categories
- Botanicals & polyphenols
- Proteins & peptides
- Probiotics & fibers
- Vitamins & minerals
- Omega-3s
- Adaptogens
- Collagen
- Cannabinoids
Product formats
- Whole foods
- Beverages
- Shots
- Gummies
- Capsules
- Tablets
- Powders
- Topicals
Our model · Science to market
Every innovation gate asks a commercial question. We add the scientific one.
Most new product processes ask whether a product can be made and sold. For science-driven products, value also depends on whether the evidence, claims and regulatory path hold up. We check for that at every gate, before it becomes expensive.
- Stage 0Discovery & ideationStrategic fit and market opportunityScientific plausibilityPortfolio strategy
- Stage 1ScopingProblem–solution fit and differentiationClaim potentialEvidence strategy
- Stage 2Business caseValue proposition and financial caseEvidence and regulatory pathRegulatory navigation
- Stage 3DevelopmentTechnical validation and scale-upProduct–evidence alignmentEvidence strategy
- Stage 4Testing & validationMarket and operational readinessClaim substantiationStakeholder engagement
- Stage 5CommercializationMarket success and scalabilityEvidence in marketLaunch · M&A diligence
Keystone Sciences and Entelec integration
Nature is the starting point. Advanced causal AI takes it further.
We start with natural compounds, such as botanicals, polyphenols and peptides, and use advanced causal AI and computational molecular engineering to design new compounds with improved stability, bioavailability and biological performance. Then we help bring them to market as differentiated products that consumers want and that can be protected.
- New compounds designed from natural starting points, creating new intellectual property opportunities
- A clear path from molecule to market: formulation, evidence, claims and positioning
Who we serve
Built for companies where the science is the product.
Our clients sit where evidence, regulation and the market meet, with particular depth in gut health and the microbiome, and in women’s health. The work changes by sector; the standard does not.
Nutraceutical companies
Helping nutraceutical brands, from botanicals to prebiotics, probiotics and postbiotics, substantiate their claims and launch products that hold up to scrutiny.
Life sciences & biotechnology
Helping biotech teams prioritize assets, design evidence programs and chart the regulatory path to market.
Consumer health & functional food platforms
Helping consumer health companies translate science into products, positioning and revenue.
MedTech innovators
Helping medtech innovators connect clinical evidence, regulatory strategy and commercial launch into one plan.
Venture investors & corporate development
Helping investors and acquirers evaluate scientific and commercial assets before they commit capital.
